Analysts forecast that NextGen Healthcare, Inc. (NASDAQ:NXGN – Get Rating) will report sales of $150.90 million for the current fiscal quarter, Zacks reports. Two analysts have provided estimates for NextGen Healthcare’s earnings. NextGen Healthcare reported sales of $144.19 million in the same quarter last year, which would suggest a positive year-over-year growth rate of 4.7%. The business is scheduled to report its next earnings report after the market closes on Monday, January 1st.
On average, analysts expect that NextGen Healthcare will report full-year sales of $594.75 million for the current year, with estimates ranging from $593.06 million to $596.00 million. For the next financial year, analysts anticipate that the firm will report sales of $633.95 million, with estimates ranging from $633.90 million to $634.00 million. Zacks’ sales averages are an average based on a survey of sell-side research firms that that provide coverage for NextGen Healthcare.
NXGN has been the topic of several analyst reports. Zacks Investment Research lowered shares of NextGen Healthcare from a “hold” rating to a “sell” rating and set a $21.00 price target on the stock. in a research report on Thursday, May 5th. StockNews.com initiated coverage on shares of NextGen Healthcare in a research report on Thursday, March 31st. They set a “strong-buy” rating on the stock. Guggenheim raised shares of NextGen Healthcare from a “neutral” rating to a “buy” rating and set a $26.00 price target on the stock in a research report on Friday, May 6th. Finally, Piper Sandler upped their price target on shares of NextGen Healthcare from $23.00 to $24.00 in a research report on Wednesday, January 26th. One analyst has rated the stock with a sell rating, two have issued a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Buy” and a consensus price target of $22.17.
NASDAQ NXGN opened at $18.66 on Thursday. The firm’s fifty day moving average price is $20.24 and its two-hundred day moving average price is $18.54. NextGen Healthcare has a 1 year low of $13.64 and a 1 year high of $21.87. The firm has a market capitalization of $1.25 billion, a P/E ratio of 1,867.87, a price-to-earnings-growth ratio of 5.57 and a beta of 1.17.
In related news, CAO David Ahmadzai sold 6,250 shares of the company’s stock in a transaction dated Tuesday, March 15th. The shares were sold at an average price of $19.55, for a total value of $122,187.50. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, EVP Donna Cullen Greene sold 63,625 shares of the company’s stock in a transaction dated Thursday, March 3rd. The shares were sold at an average price of $20.05, for a total transaction of $1,275,681.25. The disclosure for this sale can be found here. Over the last quarter, insiders sold 144,551 shares of company stock worth $2,896,091. Corporate insiders own 18.70% of the company’s stock.
Several hedge funds have recently added to or reduced their stakes in NXGN. Nisa Investment Advisors LLC acquired a new position in shares of NextGen Healthcare in the first quarter valued at about $63,000. Advisor Group Holdings Inc. grew its stake in NextGen Healthcare by 12.0% during the fourth quarter. Advisor Group Holdings Inc. now owns 5,127 shares of the company’s stock worth $92,000 after buying an additional 548 shares in the last quarter. Lazard Asset Management LLC grew its stake in NextGen Healthcare by 66.9% during the fourth quarter. Lazard Asset Management LLC now owns 5,231 shares of the company’s stock worth $93,000 after buying an additional 2,097 shares in the last quarter. Royal Bank of Canada grew its stake in NextGen Healthcare by 214.9% during the second quarter. Royal Bank of Canada now owns 5,617 shares of the company’s stock worth $93,000 after buying an additional 3,833 shares in the last quarter. Finally, IFP Advisors Inc acquired a new stake in NextGen Healthcare during the fourth quarter worth about $106,000. Institutional investors and hedge funds own 71.15% of the company’s stock.
NextGen Healthcare Company Profile (Get Rating)
NextGen Healthcare, Inc provides software and services for ambulatory healthcare services in the United States. The company offers patient engagement solutions, comprising of NextGen PxP Portal, NextGen Patient Self Scheduling, NextGen Pay, and NextGen Virtual Visits; clinical care solutions, including NextGen Enterprise HER, NextGen Mobile, NextGen Office, NextGen Behavioral Health Suite, NextGen Orthopedic Suite, and QSIDental Web and QSIDental PM; and financial management solutions, such as NextGen Enterprise PM and NextGen Clearinghouse Solutions.
Get a free copy of the Zacks research report on NextGen Healthcare (NXGN)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for NextGen Healthcare Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for NextGen Healthcare and related companies with MarketBeat.com’s FREE daily email newsletter.